SCHEMBL7666

SCHEMBL7666

COc1ccc(CCN(C)c2c(C)noc2-c2ccc(-c3ccc(C4(C(=O)O)CC4)cc3)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCC3 O15438 1/20 0.44
ABCC4 O15439 1/20 0.44
ABCB11 O95342 1/20 0.44
CYP2C8 P10632 1/20 0.44
CYP2C9 P11712 1/20 0.44
ABCB4 P21439 1/20 0.44
LPAR1 Q92633 1/20 0.44
ABCC2 Q92887 1/20 0.44
SLCO1B3 Q9NPD5 1/20 0.44
SLCO1B1 Q9Y6L6 1/20 0.44
AOC3 Q16853 1/20 0.38
POLB P06746 3/20 0.38
CHRM5 P08912 2/20 0.38
CHRM1 P11229 2/20 0.38
CHRM3 P20309 2/20 0.38
CACNA1G O43497 1/20 0.37
CACNA1H O95180 1/20 0.37
CACNA1I Q9P0X4 1/20 0.37
SLC6A9 P48067 1/20 0.37
KMT2A Q03164 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1127 0.95 LPAR1 (0.43) ABCC3ABCC4ABCB11CYP2C8CYP2C9
SCHEMBL7201 0.91 CHRM1 (0.42) ABCC3ABCC4ABCB11CYP2C8CYP2C9
SCHEMBL7026 0.88 AOC3 (0.37) AOC3POLBCHRM5CHRM1CHRM3
SCHEMBL1800 0.86 CHRM1 (0.41) ABCC3ABCC4ABCB11CYP2C8CYP2C9
SCHEMBL982 0.84 LPAR1 (0.48) ABCC3ABCC4ABCB11CYP2C8CYP2C9
SCHEMBL1239 0.84 ABCC3 (0.42) ABCC3ABCC4ABCB11CYP2C8CYP2C9
SCHEMBL6973 0.84 BRD4 (0.36) CYP2C9AOC3POLBCHRM5CHRM1
SCHEMBL6613 0.82 FFAR4 (0.35) LPAR1AOC3POLBCHRM5CHRM1
SCHEMBL13292 0.81 LPAR1 (0.49) ABCC3ABCC4ABCB11CYP2C8CYP2C9
SCHEMBL7415 0.81 LPAR1 (0.46) ABCC3ABCC4ABCB11CYP2C8CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483252-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP disclosed
WO-2011041694-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed